Objective: Nitric oxide synthase (NOS)-derived nitric oxide (NO) production is regulated posttranslationally through enzyme's inhibitory interaction with the caveolar coat protein, caveolin and stimulatory interaction with the chaperone heat shock protein, Hsp90. However, changes in the expression of these regulators with the development of hypertrophic cardiomyopathy are unknown. Methods: Histochemical and immunoblotted signals for the NOS isoforms, caveolin and Hsp90 were compared in left ventricle (LV) and aortic or mesenteric vessels between spontaneously hypertensive rats (SHR; 18 and 63 weeks old) and age-matched normotensive Wistar-Kyoto 2 (WKY) rats. To assess functional impacts on downstream NO signaling, superoxide anions (O ) and cGMP contents were measured in 2 the same tissues by oxidative fluorescent hydroethidine staining and enzyme immunoassay, respectively. Results: Compared with levels in age-matched WKY rats, endothelial NOS (eNOS) proteins were increased in aorta of SHR at 18 weeks. Conversely, aortic caveolin-1 and -3 were decreased in SHR, whereas Hsp90 remained unchanged. In LV tissue of SHR at 18 weeks, caveolin-1 and -3 were similarly decreased, but Hsp90 upregulated, together with a downregulation of eNOS. However, at 63 weeks, both eNOS and neuronal NOS (nNOS) were markedly upregulated in the LV of SHR, together with an upregulation of Hsp90. No difference in cardiac and aortic cGMP 2 contents was found between the two strains. In LV sections, O generation was higher in older compared with younger rats from both
. Introduction
present mainly in neurons, but also in cardiac, skeletal muscle and vascular smooth muscle from some vascular Nitric oxide (NO), synthesized from L-arginine by a beds, including carotid arteries [2, 3] ; and inducible (iNOS) family of nitric oxide synthases (NOS) is a key regulator expressed in response to bacterial endotoxin and a variety of multiple biological processes including the control of of proinflammatory cytokines. blood vessels tone, cardiac and vascular remodeling, In addition to transcriptional control, NOS isoforms are platelet aggregation and vascular smooth muscle cell importantly regulated at the posttranslational level. The proliferation [1] . At last three distinct NOS isoforms exist activity of all NOS enzymes is influenced by the availabiliin mammalian cells: endothelial (eNOS) expressed both in ty of their substrate, L-arginine and cofactors such as endothelial cells and cardiomyocytes; neuronal (nNOS) tetrahydrobiopterin (BH ) but also by the dynamic interac-form-specific manner. Upon binding to its consensus site mesenteric arteries from adult (18-week-old) and aging on all three isoforms, calmodulin promotes electron flow (63-week-old) male SHR (Charles River Laboratories) and from the reductase to the oxygenase domains, thereby age-matched male WKY rats. Both SHR and WKY rats enabling catalytic activity. Contrary to iNOS, calmodulin were purchased from Iffa Credo (Belgium). Animals were binding to eNOS and nNOS is largely influenced by housed in standard conditions with free access to normal intracellular concentrations of calcium. NO production by rodent food and drinking water ad libitum. Systolic arterial eNOS is negatively regulated by interaction with the pressure was measured by an automatic sphygmomanomecaveolar coat membrane proteins, caveolin-1 and -3, the ter with a tail-cuff device placed on the tail of prewarmed isoforms expressed predominantly in endothelial cells and rats. Rats were then anaesthetised with diethyl ether and cardiomyocytes, respectively [4, 5] . Direct binding of killed by exsanguination; hearts, aortas and mesenteric caveolin-3 to neuronal NOS (nNOS) also attenuates NOS vessels were immediately removed and placed in ice-cold activity [6] . This inhibitory effect has been rationalized as Krebs solution (120 mM NaCl, 5.9 mM KCl, 25 mM a reciprocal association of caveolin versus calcium / calNaHCO , 11.5 mM glucose, 1.2 mM NaH PO , 1.2 mM 3 2 4 modulin on the calcium-sensitive NOS. Conversely, the MgCl , 2.5 mM CaCl ). The hearts and vessels were 2 2 chaperone protein Hsp90, associates with both eNOS and cleaned of all adherent tissues and then frozen in liquid nNOS and stimulates the enzymes' catalytic function [7, 8] , nitrogen and stored at 280 8C until assay. All experiments perhaps through a stabilization of calmodulin binding were carried out in accordance with the Guide for the Care involving changes in phosphorylation states, at least for and Use of Laboratory Animals published by the US eNOS [9] . Hsp90 has also been implicated in the balance and pressure overload-induced hypertrophy [13] . O rapidFrozen rat LV, mesenteric artery and aortic tissues were 2 ly reacts with NO and decreases NO bioavailability. The homogenized in lysis buffer containing a protease and 2 impact of increased O production and reduced NO phosphatase inhibitor cocktail (Sigma) and centrifuged at 2 bioavailability on the NO / cGMP pathway were suggested 12 000 rpm for 10 min. Proteins were quantified using to contribute both to abnormalities of endothelium-depenbicinchoninic acid. Equal protein amounts of the boiled dent vascular relaxation [14, 15] and impairment of LV supernatant were loaded onto 8 or 12.5% SDS-PAGE gels, relaxation in LV hypertrophy [13] . Thus, an integration of and separated proteins were transferred to polyvinylidene the NOS expression and their posttranslational regulators difluoride membranes (PVDF; NEN). Naphthol blue black appears to be an important indication in assessing the staining was used to confirm equal protein loading. Imenzyme's activity and in controlling the balance between munoblotting analysis was performed as described [16] 2 NO and O . It may also provide an explanation for the with primary monoclonal antibodies for eNOS, nNOS, 2 paradoxical maintenance of bioactive NO production (as iNOS, caveolin-1, -3 or Hsp90 (1:2500 dilution for each assessed from tissue cGMP levels or sensitivity to NOS antibody), all purchased from Transduction Laboratories. inhibitors) despite reduced NOS protein abundance.
After incubation with goat anti-mouse horseradish perIn the present study, we therefore examined the concuroxidase-conjugated secondary antibodies (1:5000 dilution), rent changes in the expression of NOS isoforms and immune complexes were detected using an enhanced caveolin-1, -3 and Hsp90 proteins in left ventricular, aortic horseradish-luminol chemiluminescence reaction (NEN and mesenteric vessel tissues from a rat genetic model of Life Science Products). The density of the bands was hypertension and hypertension-induced myocardial hyperquantified by scanning densitometry. Since the main trophy (SHR), at two stages of development of the disease purpose of the study is to compare protein abundance (i.e., at 18 and 63 weeks of age), compared to WKY between WKY and SHR tissues, care was taken to load controls. In addition, we assessed cardiac production of extracts from both strains on the same gels for equal 2 superoxide anions (O ) and cGMP levels to integrate the subsequent processing and accurate comparison. Accord-2 observed expressional modifications in NOS and their ingly, results are presented as comparisons to signals in regulators with a main determinant of NO bioavailability WKY tissues on the same gels, expressed as 100%. As an and the overall functional impact on the NO / cGMP additional control, some samples were re-probed for the pathway.
expression of a-skeletal actin to account for cardiac hypertrophy.
. Methods

.3. Determination of NOS activity in left ventricular homogenates
.1. Animals
The activity of NOS was determined by conversion of [16] . Briefly, tissue extracts (100 mg of total protein) were ventricle). first antibody, i.e., a rabbit polyclonal anti-caveolin-1 2310 M in water before use. Fifty ml of hydroethidine antiserum (Transduction, 0.6 mg / ml) or a mouse IgG1 solution was topically applied to each tissue section and monoclonal anti-caveolin-3 antibody (transduction, 0.6 the slide coversliped. The slides were incubated in a mg / ml) diluted in PBS supplemented with 1% BSA, for 1 light-protected and humidified chamber (37 8C, 30 min) h. After incubation with the second antibody, i.e., rabbit before visualizing the fluorescence under a Zeiss Axiovert antisera and a rat monoclonal anti-mouse IgG1 labelled S100 (Jena, Germany) inverted microscope coupled to a with peroxidase (LO-MG1-13, 20 mg / ml), respectively, Pixera 120es digital camera. peroxidase activity was revealed according to the manufacturer's instructions (Dako). After washing under tap-water, sections were counterstained with Mayer's hematoxylin 2 .7. Statistical analysis and mounted with an aqueous mounting medium (Faramount S3025, Dako).
Data are presented as mean6S.E.M. Comparison beThe following negative controls were performed: (i) tween results from different groups were performed using omission of the first antiserum; and (ii) replacing the first Student's test or Bonferroni correction for multiple comantiserum by a rabbit polyclonal anti-a362 antiserum.
parisons where appropriate. Statistical significance was defined as P,0.05.
.5. Determination of cyclic GMP content
Frozen tissues (thoracic aorta or left ventricle) were 3 . Results homogenized in ice-cold 6% (w / v) trichloroacetic acid in the presence of the PDE inhibitor 3-isobutyl-1-methylxThe SHR were significantly hypertensive relative to the anthine (IBMX; 300 mM). After centrifugation, trichloro-WKY rats as early as 18 weeks of age. Body weights acetic acid was extracted by washing supernatants four increased in both groups during the observation period, but times with 5 volumes of water-saturated diethyl ether. The remained significantly lower in the SHR compared with remaining aqueous extract was dried under a stream of normotensive WKY rats (P,0.0001). Since heart weights nitrogen at 60 8C. Cyclic GMP contents were assayed also augmented significantly more with age and the using an acetylation protocol of an enzyme immunoassay development of hypertension in SHR compared to control kit (Amersham-Pharmacia Biotech, Little Chalfont, UK). rats, the heart weight / body weight ratios of SHR were The mean value was calculated from duplicate measuresignificantly higher compared with age-matched WKY rats ments of each sample and normalized to total protein (see Table 1 ), indicating the presence of cardiac hycontent (for thoracic aorta) or to tissue weight (for left pertrophy in SHR. (Fig. 3A) . Although the staining pattern was similar in LV vascular endothelial cells from WKY and SHR rats of both To examine the expressional modification of NOS ages, it appeared less intense in SHR rats (see Fig. 3B isoforms with hypertension we performed Western blot versus A) and in older rats from both strains (Fig. 3A ,E analysis of NOS proteins in extracts from whole left versus B,F). However, the limitation of immunohistoventricle (Fig. 1) . In LV of 18 weeks SHR, eNOS protein chemistry precludes from firm quantitative conclusion with expression was significantly lower than that found in this technique. age-matched WKY rats (Fig. 1A, left) . This decrease in
In WKY rats (both 18 and 63 weeks old), caveolin-3 young SHR was even more prominent when eNOS protein staining presented as multiple juxtaposed fine granules abundance was normalized to that of a-skeletal actin on mainly at the periphery of cardiac muscle cells. No signal the same blot, as an index of hypertrophy (Fig. 1B) . In was found in microvessels, either in smooth muscle or contrast, eNOS abundance was two times greater in SHR endothelial cells (Fig. 3C) . In SHR rats, the stained than in WKY at 63 weeks of age (Fig. 1A, right) . The granules were more sparsely distributed across the whole expression of neuronal NOS (nNOS) tended to be higher in cardiomyocyte area (Fig. 3D) . Again, no other cell type hearts of 18 weeks SHR (P: NS), and this trend was stained positively. The staining appeared more intense in clearly augmented to reach statistical significance (P, WKY compared to SHR tissues, regardless of age (see Fig.  0 .05) between WKY and SHR at 63 weeks of age (Fig.  3C versus 3D and 3G versus 3H). 1C).
We next examined changes in expression of caveolin-1 3 .3. NOS activity in LV extracts at 18 weeks and -3, two allosteric negative regulators of eNOS in endothelial cells and cardiomyocytes, respectively, in the 3 Ca-dependent NOS activity, as measured by L-[H ]citsame extracts (Fig. 2) . The abundance of caveolin-1 and -3 rulline formation, was unchanged in LV between the WKY proteins was markedly lower in whole extracts from LV of and SHR at 18 weeks of age (Fig. 4A, left) . Ca-in-18 weeks SHR compared to control WKY (P,0.0001 and dependent activity remained very low and similar in both P,0.0005, respectively, Fig. 2A,B, left) . A trend towards strains (Fig. 4A , right, P: NS). Likewise, inducible NOS a similar reduction was observed in LV of 63 weeks SHR (iNOS) was undetectable by Western blotting analysis in compared with age-matched WKY rats ( Fig. 2A,B, right) , whole ventricular extracts from either 18 and 63 weeks albeit non-significant.
WKY or age-matched SHR (not shown). Of interest, the expression of the chaperone protein Hsp90, that positively regulates eNOS (and nNOS) activity, was significantly increased in LV from 18 weeks as 3 .4. cGMP contents and superoxide production in hearts well as 63 weeks SHR compared with age-matched control extracts WKY (P,0.01 and P,0.005, respectively; Fig. 2C ).
To gain further understanding into the functional corre-3 .2. Caveolin-1 and -3 immunostaining in rat left lates to the expressional changes mentioned above, we ventricle next assessed the tissular contents of cGMP, a downstream messenger of the NO pathway, in the same LV extracts. We then examined the pattern of caveolin-1 and -3
There was no difference in LV cGMP content between immunostaining in LV of 18-and 63-week-old rats from SHR and WKY rats at any age (Fig. 4B) . both strains. Immunohistochemical detection with polyAside from NOS abundance and / or activity, the inclonal anti-caveolin-1 antibody revealed a strong granular tracellular production of cGMP depends, among various factors, on the bioavailability of the NO produced that is markedly increased in LV tissue sections from 63 weeks influenced by its oxidative degradation. Therefore, we SHR compared with age-matched WKY rats. conduit and resistance vessels, where endothelial product-NS). iNOS was undetectable in aortic tissues from 63-ion of NO modulates peripheral vascular tone. In aortic week animals of both strains. In mesenteric arteries, the rings, eNOS protein abundance was markedly increased in expression of eNOS was similar in 18 or 63 weeks WKY 18 weeks SHR compared with age-matched WKY rats and age-matched SHR (not shown). (Fig. 6A, left) . In 63 weeks SHR that was a trend towards Fig. 6B ,C illustrates variations in caveolin-1 and -3 in a reduction of eNOS expression, albeit non-significant the same aortic extracts. The abundance of caveolin-1 and (Fig. 6A, right) . The abundance of nNOS isoform in the -3 protein was decreased in 18 weeks SHR (Fig. 6B ,C, same extracts was equally unchanged (100.0630.1 in left) and 63 weeks SHR (Fig. 6B ,C, right) compared with control WKY versus 85.6610.5% in 63 weeks SHR, P:
age-matched WKY rats. 1.24660.68 pmol / mg pi in 18 weeks SHR; P: NS, and 0.17260.03 in 63 weeks WKY versus 0.21560.04 pmol / mg pi in 63 weeks SHR, P: NS). The relative changes in eNOS, nNOS, caveolin-1 / -3 and Hsp90 expression, in the heart, aorta and mesenteric arteries from adult (18-week-old) SHR and aging (63-week-old) SHR are summarized in Table 2 .
. Discussion
The main purpose of our study was to examine concurrent changes in the abundance of NOS proteins and their allosteric regulators with the development of hypertrophic cardiomyopathy in the SHR model compared with agematched WKY rats and to assess the tissue specificity of these expressional changes. We found that changes in expression of NOS between the two strains with the development of hypertension varies with time (i.e., eNOS abundance is lower in LV from younger, but higher in LV from older SHR), and according to the tissue examined (i.e., LV versus aorta). Contrary to NOS proteins, the abundance of caveolin-1 and -3 is coordinately decreased in LV and vessels. We also observed that changes in NOS abundance are not strictly reflected by concurrent changes in tissue cGMP levels. Notably, the decrease in eNOS proteins in the LV of younger SHR is paralleled with both an increase in Hsp90 protein (positive regulator of eNOS activity) and a decrease in caveolin-1 and -3 proteins (both negative regulators of eNOS activity), which may account for the unchanged cGMP levels. We also show a marked our study), eNOS protein abundance in whole heart was and aging (63 weeks; n53-5) WKY and SHR rats. Results are normalshown to either increase [18] or decrease [19] in previous ized per mg of tissue wet weight and expressed as mean6S.E.M.
studies. In contrast, Bayraktutan et al. [20] reported a selective decrease of eNOS proteins in LV cardiac Likewise, the level of caveolin-1 expression in mesenmyocytes (but not in coronary microvascular endothelial teric arteries was |2 times lower in SHR than WKY rats at cells) isolated from 12-week-old SHR. Given the increased 18 weeks (52.965.2 vs. 100610.6%; P,0.005, n59-10 mass of cardiomyocytes in hypertrophic hearts, with rats), but not at 63 weeks (not shown).
reduced capillary density, the latter observations would be The abundance of Hsp90 was unchanged in aortic consistent with our present results, showing a significant extracts across all ages and strains. In mesenteric arteries, a reduction in eNOS protein abundance in whole tissue significant increase in Hsp90 expression was observed only extracts in 18 weeks SHR compared with age-matched in SHR of 63 weeks of age (207.2615.7 in SHR versus control WKY. This reduction in eNOS was even more 100614.6% in WKY group; P,0.005; not shown).
prominent when the immunoblotting signals were normalized by those for actin (as an index of hypertrophy) in the 3 .6. cGMP contents in aortic tissue same extracts (Fig. 1B) . Unexpectedly, the reduction in LV eNOS proteins from 18 weeks SHR was not reflected by a Again, we measured tissular cGMP as an index of the reduction in total or calcium-dependent NOS activity ( . Consistent with some [21] , but not all [22] previous difference in cGMP content was found in aortic rings from studies, we found a very low calcium-insensitive NOS adult and aging SHR when compared with age-matched activity (reflective of iNOS) in all LV homogenates from control rats (1.03760.41 in 18 weeks WKY versus 18-week WKY rats similar to age-matched SHR. Accord- ingly, no signal for iNOS was detectable in LV extracts of induced by perinephritic hypertension [16] . Recently, in younger or aged animals by Western blot analysis. A the SHR model, Fujita et al. [23] found no change in potential explanation for the unchanged calcium-dependent immunoblotted caveolin-1 and -3 in the LV at 4 weeks, but NOS activity would be a compensatory increase in the a reduction in caveolin-3 at 24 weeks of age, i.e., in second calcium-sensitive NOS isoform, neuronal NOS animals 6 weeks older than those used in the present study. (nNOS), known to be expressed in the myocardium.
These changes would be expected to enhance the Indeed, the immunoblotted nNOS signal was increased in activity of the residual eNOS (and of nNOS) in the LV. 5 / 9 LV extracts of younger SHR and 5 / 5 LV extracts from Because our measurements of NOS activity were peraging SHR. The present study is, to our knowledge, the formed in a buffer containing an excess of exogenous first demonstration of increased nNOS protein expression calcium and calmodulin sufficient to dissociate the eNOSin the hypertrophic, nonfailing heart of SHR.
caveolin and nNOS-caveolin complexes, we cannot correThe reduction in LV eNOS expression of younger SHR late directly the changes in caveolin expression with was accompanied with a significant decrease in abundance calcium-dependent NOS activity in our assay (Fig. 4A) , of the NOS inhibitors, caveolin-1 and -3. Importantly, this which mostly reflects the V proportional to the abunmax contrasted with augmented levels of the heat shock protein, dance of Ca-sensitive NOS in the extracts. However, it Hsp90, a molecular chaperone known to enhance eNOS remains likely that the decreases in caveolin-1 and -3 (and and nNOS activity by facilitating calcium-calmodulin increase in Hsp90) are sufficient to enhance the ability of binding and promoting Akt phosphorylation (on eNOS eNOS and nNOS to produce NO in the intact tissue in [9] ). Only a few studies have specifically examined
vivo. Indeed, we demonstrated that a 25% reduction in expressional modifications of caveolin-1 and -3 in hycaveolin-1 was sufficient to increase basal and agonistpertrophic cardiomyopathy. Recently, we showed a reducstimulated eNOS activity in intact endothelial cells [24] . tion of caveolin-1 and -3 (and eNOS) proteins abundance Similarly, because caveolin-3 interacts with eNOS and in dogs with nonfailing, hypertrophic cardiomyopathy nNOS and negatively regulates their activity [6] , it is conceivable that a loss in caveolin-3 abundance potentiates with previous reports [18, 26] , cGMP contents of the LV not only eNOS but also nNOS activation, as reported in were unchanged across both age and strains of the animals skeletal muscle from caveolin-3 deficient transgenic mice (Fig. 4B ). Independent factors (e.g., atrial natriuretic [25] . Thus, decreases in both caveolin-1 and -3 (and Hsp90 peptide or brain natriuretic peptide) may, however, inincrease) may lead to hyperactivation of both eNOS and fluence cGMP levels in addition to NO production, includnNOS and elevations of NO production in the intact heart.
ing in the present study. Previous reports described an To address the functional impact of these expressional age-dependent increase in cardiac soluble guanylate changes, we measured tissular contents of cGMP, a major cyclase (sGC) and cGMP-dependent protein kinase type I downstream messenger of the NOS pathway. Consistent (cGKI) expression [27] as well as cardiac cGMP content, Table 2 the aorta of 18 weeks SHR, whereas it decreases in the LV of Hsp90, a downregulation of these eNOS inhibitors would again contribute to maintain NO production in the but in much older (17-and 22-25-month-old, respectively) face of a well-established increased oxidant stress in the WKY rats than those in our experiments. On the contrary, vascular wall of hypertensive animals [15, 31] . NOS activiKojda et al. [28] reported that NO donors-induced activity ty may also be reinforced by the simultaneous upregulation of the soluble GC-cGMP system in cardiac muscle is not of nNOS in the vascular media, as previously observed by altered in long-term hypertension. These results, together others [3, 36] . As in LV extracts, the increased oxidant with our present observations indicate that in hypertrophic stress likely explains the unchanged aortic cGMP contents. nonfailing heart of SHR, the level of bioactive NO can be
In conclusion, ours results establish the tissue-and partially depressed and insufficient to upregulate guanylate isoform-specific regulation of NOS in the SHR, which, in cyclase despite potentially increased NOS function.
most cases, contrasts with opposite changes in the abunSeveral groups reported an exaggerated production of dance of allosteric regulators such as caveolins and Hsp90.
2 superoxide anion (O ) by the vascular wall in SHR and Such discordance emphasizes the need to assess parallel 2 other models of hypertension [11, 12] others in rat aortic rings [31] . Therefore, increased O National de la Recherche Scientifique.
2 production plausibly explains the unchanged cGMP levels despite increased NOS abundance and / or activity in the LV of older SHR. The coordinated expressional changes in R eferences NOS isoforms and their allosteric regulators, such as caveolin and Hsp90, may even be viewed as a compensat- the heart of 63 weeks SHR. 
